×
News Home

Can Aurinia Pharmaceuticals Inc (AUPH) Stock Rise to the Top of Healthcare Sector Wednesday?

Wednesday, September 15, 2021 11:49 AM | InvestorsObserver Analysts
Can Aurinia Pharmaceuticals Inc (AUPH) Stock Rise to the Top of Healthcare Sector Wednesday?

Aurinia Pharmaceuticals Inc (AUPH) is around the top of the Healthcare sector according to InvestorsObserver. AUPH received an overall rating of 66, which means that it scores higher than 66% of stocks. Additionally, Aurinia Pharmaceuticals Inc scored a 96 in the Healthcare sector, ranking it higher than 96% of stocks in that sector.

Overall Score - 66
AUPH has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on AUPH!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Aurinia Pharmaceuticals Inc Stock Today?

Aurinia Pharmaceuticals Inc (AUPH) stock is lower by -2.77% while the S&P 500 has gained 0.25% as of 11:43 AM on Wednesday, Sep 15. AUPH is lower by -$0.59 from the previous closing price of $21.50 on volume of 2,397,652 shares. Over the past year the S&P 500 is up 30.96% while AUPH has gained 40.24%. AUPH lost -$1.25 per share the over the last 12 months. Click Here to get the full Stock Report for Aurinia Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App